HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Greater Somatosensory Afference With Acupuncture Increases Primary Somatosensory Connectivity and Alleviates Fibromyalgia Pain via Insular γ-Aminobutyric Acid: A Randomized Neuroimaging Trial.

AbstractOBJECTIVE:
Acupuncture is a complex multicomponent treatment that has shown promise in the treatment of fibromyalgia (FM). However, clinical trials have shown mixed results, possibly due to heterogeneous methodology and lack of understanding of the underlying mechanism of action. The present study was undertaken to understand the specific contribution of somatosensory afference to improvements in clinical pain, and the specific brain circuits involved.
METHODS:
Seventy-six patients with FM were randomized to receive either electroacupuncture (EA), with somatosensory afference, or mock laser acupuncture (ML), with no somatosensory afference, twice a week over 8 treatments. Patients with FM in each treatment group were assessed for pain severity levels, measured using Brief Pain Inventory (BPI) scores, and for levels of functional brain network connectivity, assessed using resting state functional magnetic resonance imaging (MRI) and proton magnetic resonance spectroscopy in the right anterior insula, before and after treatment.
RESULTS:
Fibromyalgia patients who received EA therapy experienced a greater reduction in pain severity, as measured by the BPI, compared to patients who received ML therapy (mean difference in BPI from pre- to posttreatment was -1.14 in the EA group versus -0.46 in the ML group; P for group × time interaction = 0.036). Participants receiving EA treatment, as compared to ML treatment, also exhibited resting functional connectivity between the primary somatosensory cortical representation of the leg (S1leg ; i.e. primary somatosensory subregion activated by EA) and the anterior insula. Increased S1leg -anterior insula connectivity was associated with both reduced levels of pain severity as measured by the BPI (r = -0.44, P = 0.01) and increased levels of γ-aminobutyric acid (GABA+) in the anterior insula (r = 0.48, P = 0.046) following EA therapy. Moreover, increased levels of GABA+ in the anterior insula were associated with reduced levels of pain severity as measured by the BPI (r = -0.59, P = 0.01). Finally, post-EA treatment changes in levels of GABA+ in the anterior insula mediated the relationship between changes in S1leg -anterior insula connectivity and pain severity on the BPI (bootstrap confidence interval -0.533, -0.037).
CONCLUSION:
The somatosensory component of acupuncture modulates primary somatosensory functional connectivity associated with insular neurochemistry to reduce pain severity in FM.
AuthorsIshtiaq Mawla, Eric Ichesco, Helge J Zöllner, Richard A E Edden, Thomas Chenevert, Henry Buchtel, Meagan D Bretz, Heather Sloan, Chelsea M Kaplan, Steven E Harte, George A Mashour, Daniel J Clauw, Vitaly Napadow, Richard E Harris
JournalArthritis & rheumatology (Hoboken, N.J.) (Arthritis Rheumatol) Vol. 73 Issue 7 Pg. 1318-1328 (07 2021) ISSN: 2326-5205 [Electronic] United States
PMID33314799 (Publication Type: Journal Article, Randomized Controlled Trial, Research Support, N.I.H., Extramural)
Copyright© 2020, American College of Rheumatology.
Chemical References
  • gamma-Aminobutyric Acid
Topics
  • Adult
  • Afferent Pathways
  • Cerebral Cortex (diagnostic imaging, metabolism)
  • Electroacupuncture (methods)
  • Female
  • Fibromyalgia (diagnostic imaging, metabolism, therapy)
  • Functional Neuroimaging
  • Humans
  • Magnetic Resonance Imaging
  • Middle Aged
  • Neural Pathways
  • Pain Measurement
  • Proton Magnetic Resonance Spectroscopy
  • Somatosensory Cortex (diagnostic imaging)
  • gamma-Aminobutyric Acid (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: